ArticleThe Journal of biological chemistry2018

Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC).

Yifan Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.